Pharma bosses call for higher drug prices in EU to counter tariff threat

Drug firm bosses call for price increases in Europe amid tariff uncertainty

The boss of AstraZeneca said Europe should increase spending on health treatment in line with recent commitments on defence.

Pharma bosses call for higher drug prices in EU to counter tariff threat

Novartis and Sanofi CEOs push for European benchmark against US prices

Novartis and Sanofi are calling for higher drug prices in Europe. In an open letter published Wednesday by the British newspaper Financial Times, they argue that the EU should adjust its prices to a level closer to that of the United States.

The pharmaceutical companies Novartis and Sanofi demand higher drug prices in Europe in an open letter published on Wednesday in the Financial Times. The European Union should adapt the drug prices more closely to the high US level.

The competitiveness of European suppliers is dwindling, and customs uncertainty further reduces incentives for investment in the EU.